Search Results
Results found for "Roger Sunahara"
Posts (3)
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
Tim Dyer, CEO, Roger Mills, CMO and Robert Lütjens, Head of Discovery Biology, will provide a business
- Nanobodies: New Dimensions in GPCR Signaling Research
S., Schnapp, A., Konetzki, I., Sunahara, R. K., Gellman, S. H., Pautsch, A., Steyaert, J., Weis, W.
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
.; Robers, M. B.; Machleidt, T.; Wood, K. V.; Hill, S. J.; Pfleger, K. D. G.
Other Pages (4)
- Dr. Roger Sunahara | Dr. GPCR Ecosystem
Roger Sunahara About Dr. Roger Sunahara Professor Sunahara received his graduate training with Dr. In 2015 Professor Sunahara moved his laboratory to the Department of Pharmacology at the University of The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G The Sunahara lab has also been developing protein-based therapeutics using structure-guided design and Roger Sunahara on the web UCSD Profile Google Scholar ResearchGate LinkedIn Dr.
- Dr. Gunnar Schulte | Dr. GPCR Ecosystem
first with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology; 2003-2005) and later with Roger
- Dr. Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem
self-experimentation with TRH and somatostatin, and first encounters with hormones and GPCRs. 02:00 — Move to Roger




